Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good day, and welcome to The Hanover Insurance Group’s Fourth ...

Roche achieved a sales growth of 7% (3% in CHF) in 2024, citing strong demand for pharmaceutical products. As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor ...

Shares of RHHBY opened at $39.25 on Thursday. Roche has a 52-week low of $29.20 and a 52-week high of $42.43. The company has a 50-day simple moving average of $36.22 and a 200-day simple moving ...

Eli Lilly (LLY) stock rises as company posts Q4 2024 results, beating expectations with a twofold rise in revenue from weight ...

Pfizer's late-stage BRAF V600E-mutant mCRC study of the Braftovi combo regimen meets its other dual primary endpoint of PFS ...

At close: 3 February at 3:50:06 pm GMT+1 ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Lonza Group AG plans to focus on CDMO segment, despite revenue decrease. Click here to read more on the analysis of LZAGY stock.

Long-serving Roche chief executive Severin Schwan is stepping down, to be replaced next March by Thomas Schinecker, currently head of diagnostics at the Swiss group. Schwan (pictured above ...

Morning sunlight falls on the facade of the New York Stock Exchange (NYSE) building in Manhattan in New York City, New York, U.S., January 28, 2021. REUTERS/Mike Segar/File Photo The S&P 500 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...